JP2024507638A5 - - Google Patents
Info
- Publication number
- JP2024507638A5 JP2024507638A5 JP2023540524A JP2023540524A JP2024507638A5 JP 2024507638 A5 JP2024507638 A5 JP 2024507638A5 JP 2023540524 A JP2023540524 A JP 2023540524A JP 2023540524 A JP2023540524 A JP 2023540524A JP 2024507638 A5 JP2024507638 A5 JP 2024507638A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- composition
- sexual
- composition according
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163142840P | 2021-01-28 | 2021-01-28 | |
| US202163142833P | 2021-01-28 | 2021-01-28 | |
| US63/142,833 | 2021-01-28 | ||
| US63/142,840 | 2021-01-28 | ||
| PCT/US2022/014075 WO2022165017A1 (en) | 2021-01-28 | 2022-01-27 | Use of neuroactive steroids for treatment of sexual dysfunction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507638A JP2024507638A (ja) | 2024-02-21 |
| JP2024507638A5 true JP2024507638A5 (https=) | 2025-02-03 |
Family
ID=80787167
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023540524A Pending JP2024507638A (ja) | 2021-01-28 | 2022-01-27 | 性機能障害処置のための神経刺激性ステロイドの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240122945A1 (https=) |
| EP (1) | EP4284382A1 (https=) |
| JP (1) | JP2024507638A (https=) |
| KR (1) | KR20230136599A (https=) |
| AU (1) | AU2022214187A1 (https=) |
| CA (1) | CA3206537A1 (https=) |
| IL (1) | IL304080A (https=) |
| MX (1) | MX2023008726A (https=) |
| WO (1) | WO2022165017A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2882708A1 (en) | 2012-08-21 | 2014-02-27 | Sage Therapeutics, Inc. | Methods of treating epilepsy or status epilepticus |
| KR102396328B1 (ko) | 2013-04-17 | 2022-05-10 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| WO2016082789A1 (en) | 2014-11-27 | 2016-06-02 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| EP3504189A1 (en) | 2016-08-23 | 2019-07-03 | Sage Therapeutics, Inc. | A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid |
| MA51046A (fr) | 2017-12-08 | 2021-03-17 | Sage Therapeutics Inc | Dérivés de 21-[4-cyano-pyrazol-1-yl]-19-nor-pregan-3. alpha-ol-20-one deutérés pour le traitement de troubles du snc |
| PE20240780A1 (es) * | 2021-07-28 | 2024-04-17 | Sage Therapeutics Inc | Formas cristalinas de un esteroide neuroactivo |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA200801081A1 (ru) * | 2005-10-14 | 2008-10-30 | Х. Лундбекк А/С | Способы лечения расстройств центральной нервной системы комбинацией малых доз эсциталопрама и бупропиона |
| KR102396328B1 (ko) | 2013-04-17 | 2022-05-10 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| EP3068226A4 (en) * | 2013-11-11 | 2017-05-17 | Euthymics Bioscience, Inc. | Novel methods |
| ES2805598T3 (es) | 2014-05-29 | 2021-02-12 | Sage Therapeutics Inc | Esteroides neuroactivos, composiciones y usos de los mismos |
| KR20240157128A (ko) * | 2016-03-08 | 2024-10-31 | 세이지 테라퓨틱스, 인크. | 신경활성 스테로이드, 조성물, 및 그의 용도 |
| EP3504189A1 (en) | 2016-08-23 | 2019-07-03 | Sage Therapeutics, Inc. | A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid |
| CA3103421A1 (en) * | 2018-06-12 | 2019-12-19 | Sage Therapeutics, Inc. | A 19-nor c3,3-disubstituted c21 -n-pyrazolyl steroid and methods of use thereof |
| US20220125803A1 (en) * | 2019-03-04 | 2022-04-28 | Praxis Precision Medicines, Inc. | Methods for the treatment of perimenopause and menopause |
-
2022
- 2022-01-27 KR KR1020237025051A patent/KR20230136599A/ko active Pending
- 2022-01-27 AU AU2022214187A patent/AU2022214187A1/en active Pending
- 2022-01-27 CA CA3206537A patent/CA3206537A1/en active Pending
- 2022-01-27 US US18/263,189 patent/US20240122945A1/en active Pending
- 2022-01-27 WO PCT/US2022/014075 patent/WO2022165017A1/en not_active Ceased
- 2022-01-27 IL IL304080A patent/IL304080A/en unknown
- 2022-01-27 JP JP2023540524A patent/JP2024507638A/ja active Pending
- 2022-01-27 MX MX2023008726A patent/MX2023008726A/es unknown
- 2022-01-27 EP EP22704661.2A patent/EP4284382A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024507638A5 (https=) | ||
| Bartlik et al. | Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors | |
| Damluji et al. | Paradoxical worsening of depressive symptomatology caused by antidepressants | |
| JP2003503450A5 (https=) | ||
| JP2021519267A5 (https=) | ||
| AR069260A1 (es) | Compuesto 1-[2-(2, 4-dimetilfenilsulfanil)fenil]piperazina.usos terapeuticos de compuestos que tienen actividad combinada de sert (transportador de serotonina), 5-ht3 (receptor 3 de 5-hidroxitriptamina) y 5-ht1a (receptor 1a de 5-hidroxitriptamina).metodo de tratamiento. | |
| KR20230136599A (ko) | 성 기능장애의 치료를 위한 신경활성 스테로이드의용도 | |
| JP2024515829A5 (https=) | ||
| RU97119427A (ru) | Сочетание ингибитора усвоения 5-нт с селективным 5-нтia антагонистом | |
| EP4494701A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| Power-Smith | Beneficial sexual side-effects from fluoxetine | |
| JP2002518442A (ja) | 偏頭痛及び情動病の治療及び予防用バルプロ酸類似物の用法 | |
| Lees | Levodopa substitution: the gold standard | |
| JP2009502945A (ja) | 覚醒を改善する方法 | |
| JP2004002474A (ja) | 純粋なフルオキセチンのｓ（＋）異性体を用いる組成物 | |
| JP2005531594A5 (ja) | 慢性痛の治療用トリプルモノアミン再取り込み阻害剤 | |
| US6943193B1 (en) | Method for treating sexual dysfunction | |
| CN1281222C (zh) | 预防和治疗过早射精和/或性兴奋超敏反应的药物组合物 | |
| JP2519148B2 (ja) | うつ病治療剤 | |
| WO2018109935A1 (ja) | Ｐｔｓｄ患者において悪夢を予防、改善、又は治療する薬剤 | |
| RU2192813C1 (ru) | Способ воздействия на микроциркуляцию при повреждениях переднего отрезка глаза | |
| EP0651638A1 (en) | Pharmaceutical composition and method of treatment for serotonin depletion illness | |
| RU2440155C1 (ru) | Способ лечения климактерического синдрома | |
| RU2323018C1 (ru) | Способ лечения эректильной дисфункции, ассоциированной с гипертонической болезнью, у больных хроническим простатитом | |
| RU2696782C1 (ru) | Способ купирования резистентных депрессивных синдромов психосоматического круга |